Winthrop Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-180
Closed -$20K 359
2025
Q1
$20K Hold
180
0.01% 189
2024
Q4
$19K Hold
180
0.01% 203
2024
Q3
$19K Hold
180
0.01% 107
2024
Q2
$20K Hold
180
0.01% 98
2024
Q1
$24K Buy
180
+60
+50% +$7.5K 0.01% 99
2023
Q4
$14.6K Buy
+120
New +$13.4K ﹤0.01% 203

Other funds holding ZBH

Winthrop Capital Management's ZBH Position: Q2 2025 in Review

Winthrop Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 180 shares — an estimated $20K sold.

Winthrop Capital Management first reported a position in ZBH in Q4 2023 and held it in 6 quarters. The position peaked at $24K in Q1 2024. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Winthrop Capital Management reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Winthrop Capital Management sold 180 Zimmer Biomet shares in Q2 2025, an estimated $20K.
  • Winthrop Capital Management first reported a position in Zimmer Biomet in Q4 2023 and held it in 6 quarters.
  • Winthrop Capital Management's Zimmer Biomet position peaked at $24K in Q1 2024.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Winthrop Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.